Clinical supply fragility can delay trials, erode value, and expose hidden risks. Strong planning and resilient networks are now critical for success.
- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead
- The Firefighting Era Of Clinical Supply Chain Is Over. Here's What Replaces It
- Navigating FDA Inspections: Practical Steps For Clinical Supply Leaders, Part 2
- Regulatory Readiness In Clinical Supply: Building A Culture Of Compliance, Part 1
- Optimizing Clinical Trial Supply Chains For Epidemic Response
- The High Cost Of Zero Waste: Protecting Patients In Clinical Supply
- From Crisis Response To Repeatable Resilience In Clinical Supply
- Transitioning Into A Clinical Trial Supply Chain Study Lead Role
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Planning For The Return And Destruction Of Your Product
Aspects of accountability, reconciliation, return, and destruction require significant effort to compile historical data. A little up-front planning can remove many future complications.
-
3 Reasons Sponsors Should Own The RTSM Vendor Relationship
Explore how direct management of study randomization and supply chains reduces communication delays, improves system design, and protects clinical data integrity from accidental unblinding.
-
The Patient-Centric Clinical Supply Chain For Cell And Gene Therapies
This article explores how delivering cell and gene therapies to patients requires new levels of agility, flexibility and innovation in the logistical management of supply.
-
Powering Complex Personalized Medicine Oncology Trial
Managing custom therapies requires a synchronized supply chain. Learn how to bridge the gap between manufacturing and clinical workflows to ensure seamless patient care in complex oncology trials.
-
Avoiding The Risk Of A Non-Transparent Clinical Supply Solution
With the supply chain and transportation logistics disruption caused by the COVID-19 pandemic, full documentation and complete transparency becomes even more important to avoid delays and assert provenance.
-
Navigating The Biopharma Finance And Accounting Tech Landscape
During clinical trials, the intricacies of financial management intensify, necessitating advanced ERP functionalities to handle clinical accruals, compliance, and reporting.
-
The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented Systems
Here we examine two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.
-
How Modern Software Architecture Is Revolutionizing IRT Solutions
Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.
-
Lifecycle Planning For Containment And Delivery Of Biologics Drug Products
Read more about trends in the biologics market that could impact the lifecycle strategies for your drug product and steps you can take around drug packaging early in development.
-
Roles And Responsibilities Of Specialized Clinical Supply Experts
Explore the important roles of the Project Manager, Clinical Supply Manager, and Financial Project Analyst, whose responsibilities contribute to clinical supply expertise and study success.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.